Chambal Fertilisers & Chemicals Ltd

- Technical Ammonium Nitrate (TAN) project: EPC work 92% complete; scheduled completion by April 30, 2026; active focus area with vertical and horizontal expansion being actively explored. - Joint venture IMACID: Capacity expansions underway, increasing P2O5 production from 5 lakh to 7 lakh metric tons by December 2026; sulfuric acid capacity increase expected in FY 27. - Exploring asset acquisition through models similar to TERI for R&D and manufacturing collaborations rather than outright acquisitions at present. - Overseas investments: Active and positive re-engagements in discussions, though no concrete outcome yet. - Seed business: Scaling up after initial market tests; considering tie-ups or stake offerings with MNCs. - No immediate capital allocation plans beyond TAN expansion; future possibilities for returns or investments depend on progress.

- Urea volumes expected to remain largely static as plants operate beyond 100% capacity; potential growth linked to extending turnaround cycles from two to three years, unlocking unexploited capacity. - Complex fertilizers showing strong growth with significant volume increases (e.g., 81% revenue increase in quarter); demand expected to remain robust. - TAN project progressing with commissioning expected by April 2026; target capacity utilization 75-80%+ by FY '27. - Expansion in TAN is a key focus, with active exploration of vertical (value chain forward integration) and horizontal (capacity increase) growth opportunities. - CPC Speciality Nutrients and Seed segment showing healthy momentum; pipeline for 8-9 new products till 2028 with IP control, supporting portfolio expansion. - Market growth in TAN (5-6% CAGR) expected amid increasing infrastructure and mining activity in India. - No concrete overseas investments or asset acquisitions immediately planned; evaluating opportunities cautiously. - Government subsidy and receivable cycles continue with stable flows supporting revenue.

- Urea volumes are expected to remain largely static as plants operate beyond 100% capacity; potential for some unexploited capacity on extending turnaround cycles from two to three years (Page 15). - Complex fertilizer segment showed strong growth with an 81% increase in quarterly revenues and improved EBIT margins, indicating growth potential (Page 5-6). - CPC Specialty Nutrients and Seed segment continues robust growth, expanding portfolio and improving market penetration, supporting future earnings increase (Page 5). - TAN plant expected to ramp up utilization to 75%-80% plus by FY '27, which would contribute positively to earnings (Page 7). - No immediate increase in cash returns to shareholders anticipated in next 1-2 years; focus remains on expansion (Page 14). - Strong subsidy receipts and receivables management support stable cash flows (Page 5, 15). - Margins remain steady in urea; complex fertilizers and specialty segments showing improved profitability indicating diversified future earnings growth (Page 5, 6).

- As of end of December, Chambal Fertilisers had outstanding receivables around INR 1,980 crores. - Of this, approximately INR 600-700 crores have been billed. - The balance amount is unbilled due to processes like POS clearance and freight adjustments. - By January and February, around INR 1,000 crores have been received. - The government has provided supplementary grants for the sector, which adds comfort regarding receivables. - While there are pending subsidy dues from the government, the company indicated the cycle of payments goes back and forth, and they are comfortable with the current status. - No specific orderbook figures were mentioned beyond receivables and subsidies discussed.

- Currently, there is no mention of any specific new fundraising through debt or equity. - Management indicated that after the TAN plant expansion and any potential inorganic opportunities, there are no plans for capital allocation towards shareholder returns or new fundraising in the next one to two years. - Discussions and active exploration of horizontal and vertical expansions in the TAN segment continue, but no concrete financing plan has been disclosed yet. - Overseas investment talks are ongoing with active re-engagements, but no definite fundraising announcement has been made. - The company appears focused on internal cash generation and strategic expansions rather than immediate debt or equity raises.